Mandatory Drug Testing of Dental Students: To Test or Not to Test by Gibson, Tanya Marie et al.
924 Journal of Dental Education ■ Volume 83, Number 8
Point/Counterpoint
Mandatory Drug Testing of Dental Students: 
To Test or Not to Test 
Viewpoint 1: Drug Testing of Dental Students Should Be 
Mandatory for the Beneit of Students, Institutions, Patients,  
and the Profession 
Tanya Marie Gibson, Maria A. Loza-Herrero, Juan F. Yepes 
Viewpoint 2: Mandatory Drug Testing of Dental Students  
Carries Costs and Risks for Institutions and Students and  
Has Unproven Beneits 
Hera Kim-Berman, Deborah A. Dilbone, Herminio Perez 
Abstract: An educational institution’s decision to test or not test its students for drug use is controversial and complex. Although 
negative consequences of substance use disorder are well known, the consumption of prohibited substances continues to increase 
in young adults. Given the awareness of increasing drug use on college campuses and the potential impact on future health care 
professionals, issues associated with mandatory drug testing of dental students warrant investigation. The purpose of this Point/
Counterpoint article is to present opposing viewpoints on whether mandatory student drug testing (MSDT) should be imple-
mented for dental students. Viewpoint 1 airms that MSDT is legal, ensures public safety, is recognized as a need in health care 
education, promotes professional and ethical responsibility, and is cost-efective. Viewpoint 2 asserts that MSDT has not been 
proven to be an efective deterrent for student drug use and it poses risks and costs for both institutions and students, ranging 
from potential violation of students’ civil liberties to the consequences of false positive tests. This article’s presentation of the 
recent literature on both sides of this issue provides dental educators with pertinent information for considering implementation 
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T
he 2016 National Survey on Drug Use and 
Health found that illicit drug use in college 
students and adults increased from 34% to 
43% over the ten-year span from 2006 to 2016.1 Other 
reports have noted that nonmedical use of drugs 
among medical and dental students and early career 
physicians has increased since the mid-1960s.2-7 In 
one survey, dental students self-reported that 71.7% 
used alcohol and 15% used medications to increase 
their focus while studying.8 According to Bell et al., 
many state legislatures have decriminalized, legal-
ized, or medically sanctioned the use of cannabis.9 In 
doing so, the lines have become blurred concerning 
the acceptability of drug use in the workplace and in 
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society. To add to the complexity of this issue, each in-
stitution must consider both federal and state laws when 
considering which drugs to include in a drug-testing 
panel and how the legalization of once-illicit drugs, 
such as cannabis, and prescribed opioids would factor 
into the decision. Institutions of higher education are 
also mandated by the Drug-Free Schools and Com-
munities Act (DFSCA) of 1986 and its 1989 amend-
ments to examine methods for preventing illegal use 
of alcohol and other drugs on their campuses.10-12 
The decision to test students for illicit drug use, 
made by educators responsible for training future 
health care professionals, can be inluenced by the 
increased prevalence of drug use by young adults and 
changing societal views in conjunction with federal 
and state mandates. Although some health profes-
sions schools have opted to implement some type of 
student drug testing program,13-15 we are not aware of 
any current national consensus on drug testing stu-
dents in the health professions. Given the awareness 
of increased use of drugs on college campuses and 
the potential impact on future health professionals, 
the ethical, legal, medical, public safety, and practi-
cal issues associated with mandatory drug testing of 
dental students should be considered.1,16-19 
The purpose of this Point/Counterpoint article 
is to present opposing viewpoints on whether man-
datory student drug testing should be implemented 
for dental students. The scope of the discussion 
focuses mainly on non-medical use of prescription 
medication, illicit drugs, and cannabis even though 
we acknowledge that alcohol, albeit legal, is the most 
frequently abused substance among young adults. 
Viewpoint 1: Drug 
Testing of Dental Students 
Should Be Mandatory for 
the Beneit of Students, 
Institutions, Patients, and 
the Profession 
With increased illicit drug use and misuse of 
prescription drugs, many employers and some pro-
fessional schools have instituted mandatory student 
drug testing (MSDT).13,15,20-23 In its evaluation of drug 
use among health professions students, a study pub-
lished in 2006 reported that 3.6% of dental students, 
3.3% of allied health students, 2.2% of medical 
students, 3.9% of nursing students, and 1.6% of 
pharmacy students self-reported performing patient 
care while under the inluence.20 A review of alcohol 
and drug use among second-year medical students 
at the University of Leeds in the UK published in 
2000 reported that 33.1% used illicit drugs.6 A sur-
vey in 2011 found that more than 20% of students 
admitted to the McWhorter School of Pharmacy in 
Birmingham, AL, self-reported current or past use of 
illegal substances.21 In a preliminary survey of dental 
students regarding health issues, 71.7% reported the 
use of alcohol, and 15% reported using medications 
to increase focus while studying.8 This self-reported 
data by dental and other health professions students 
show that a portion of our students are engaging in the 
use of alcohol or drugs. Since dental students provide 
health care to patients, schools and hospitals must take 
the necessary steps to protect the public. As educators, 
we have a professional and ethical obligation to ensure 
that dental care is provided in a safe environment, 
which includes care by unimpaired individuals who 
do not use illicit drugs or have substance use disorder 
(SUD). A diagnosis of SUD is based on evidence of 
impaired control, social impairment, risky use, and 
pharmacological criteria.24 There is cause for concern 
since SUD in the U.S. afects approximately 10% 
of the general population, and this percentage was 
similar for one group of dentists.1,25 There is also 
evidence that, for some, SUD may have emerged 
during medical school and residency training.9 
The self-reported survey data on health profes-
sions students and drug use along with the increased 
prevalence of drug use warrant strong consideration 
of implementing MSDT in dental schools. This 
viewpoint argues that MSDT is legal, ensures public 
safety, is recognized as a need in health care educa-
tion, promotes professional and ethical responsibility, 
and is cost-efective. 
MSDT Is Legal
In the U.S., if there is a prior agreement in 
place between the individual being tested and the 
entity performing the test, drug testing is legal.19 
Controversy only arises when that agreement is not 
in place and the individual is subjected to drug test-
ing. Based on this premise, dental schools are able to 
legally impose MSDT. MSDT could be a prerequisite 
for entering dental school as well as part of the aca-
demic program. Some dental schools have already 
implemented such programs.13,15
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According to Luna, the U.S. Supreme Court 
has upheld drug testing for railroad employees.26 
The court found minimal intrusion in privacy, given 
the nature of the testing procedures. Any privacy 
concerns were outweighed by the need to prevent 
railroad employees from being involved in drug use 
and causing accidents that can be life-threatening. 
The Supreme Court also made it clear that public 
schools and universities have a “green-light” to drug 
test students involved in extracurricular activities. 
Drug testing of dental students should mirror some 
variation of programs previously implemented in 
athletics, aviation, military forces, federal services, 
and some health care professions.
Public Safety
The National Institutes of Health (NIH) re-
ported that over two million Americans have opioid 
use disorder, which may impair the mental and or 
physical ability required for the performance of 
potentially hazardous tasks.27 Health care providers 
working under the inluence of drugs are a threat 
to public safety because their ability to care for the 
well-being and safety of their patients is impaired. 
Ensuring the safety of the public is a primary concern 
for employers including hospitals, where many dental 
students enroll in postgraduate residency programs. 
Many federal agencies, such as the U.S. Department 
of Transportation, U.S. Department of Defense, and 
U.S. Nuclear Regulatory Commission’s Fitness for 
Duty Programs (according to drugabuse.gov), require 
a drug-free workplace and conduct drug testing to 
deter personnel from using illicit drugs and misusing 
prescription drugs that impact executive functions. 
It is also imperative that we remain mindful of 
the changing culture concerning drug use, especially 
with the epidemic of SUD involving opioids and the 
legalization of cannabis. Crean et al. reported in their 
review of efects of cannabis on executive cognitive 
functions that, even though deicits in cognitive and 
motor function resolve after a period of abstinence, 
the length of time may be 28 days or longer.28 Those 
authors also reported on a study that compared deci-
sion making and risk-taking in cannabis users and 
cocaine users after 25 days of abstinence and found 
similar impairment in both groups, which was sig-
niicant when compared to non-using controls. The 
most enduring long-term efect of cannabis use is a 
deicit in decision making, which has also been found 
in patients using other drugs such as cocaine and 
methamphetamines.29-32 While the number of states 
legalizing the use of cannabis has been increasing, 
the Department of Transportation continues to for-
bid its pilots, school bus drivers, truck drivers, train 
engineers, subway operators, aircraft maintenance 
personnel, transit fire‐armed security personnel, 
ship captains, pipeline emergency response person-
nel, and others from cannabis use in the interest of 
public safety.33 
Dentistry is one of the ields whose practitio-
ners are likely to encounter stress, depression, and 
SUD.34 Among the most notable factors are avail-
ability of the medication and experimentation in 
conjunction with induced job stress. One of the most 
deleterious efects of SUD in health care providers 
is the potential harm to patients. One study of oral 
and maxillofacial surgery residents and illicit drug 
use reported “consistent charting errors, isolated 
or withdrawn from peers, increased tardiness or 
absenteeism, increased labile mood with frequent 
unexplained anger and overreaction to criticism, 
increased di culty with authority, dishonesty, and 
tremors.”35 If SUD afects 10% of our dental students, 
it may be inferred that MSDT would protect a certain 
percentage of our patients from being treated by a 
dental student who is under the inluence. 
Another potential benefit of implementing 
MSDT is that it could identify students who use and 
abuse drugs and help them get into prevention pro-
grams at an early stage in their careers. Similar to high 
school athletic programs that implement MSDT, if a 
student is found to have a positive drug test, a number 
of benchmarks could be met including “mandatory 
counseling, referral to a drug treatment facility, and 
passing subsequent drug tests” to facilitate recovery 
prior to returning to their educational curriculum.36 
Student afairs oices (or the equivalent) can play a 
critical role in referring dental students with positive 
test results for appropriate SUD treatment programs. 
Such prevention programs could reduce the numbers 
of dental students that use illicit drugs and are at risk 
for SUD. MSDT combined with a robust substance 
abuse educational program may prove to be beneicial 
for not only the individuals battling SUD, but also 
for those who may indirectly be afected by SUD. 
This process gives schools not only the ability to 
help with intervention and prevention for the health 
of our students but also to promote the safety of our 
patients. It is time to adjust our practices to adapt to 
the changing times to ensure the safety of our patients 
and the potential need for intervention for students 
and future dentists at risk of developing SUD.
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Recognized Need for Drug Testing
At least two higher education institutions 
have recently instituted mandatory drug testing for 
admissions.13,37 The American Association of Col-
leges of Pharmacy (AACP) recommends that all 
U.S. pharmacy schools drug-screen students upon 
conditional acceptance (www.aacp.org/resource/
drug-screenings). One of the main reasons given for 
conducting the screenings is to enhance the safety 
and well-being of patients while increasing the pub-
lic’s trust in the profession. The School of Medicine 
at Oregon Health and Science University (OHSU) 
requires all faculty, staf, and students involved in 
patient care to have a drug-screening test.37 Enter-
ing medical students at OHSU must complete the 
drug-screening test in the irst month of enrollment 
and can be tested for cause any time during their 
medical education program. The University of Mis-
souri School of Nursing and the Dietetics, Nuclear 
Medicine, Radiography, Respiratory Therapy, and 
Ultrasound programs require a Panel 14 Drug Screen 
Test, which includes amphetamines, barbiturates, 
benzodiazepines, cannabinoids, cocaine, ethanol, 
ketamine, meprobamate, methadone, meperidine, 
opiates, oxycodone, propoxyphene, and tramadol.13 
Students enrolled in the University of Missouri 
School of Medicine’s Occupational Therapy, Physi-
cal Therapy, Child Life, Clinical Lab Sciences, and 
Athletic Training programs need a Panel 8 Drug 
Screen, which includes amphetamines, barbiturates, 
benzodiazepines, cannabinoids, cocaine, ethanol, 
opiates, and phencyclidine (PCP). 
Two studies examined the effects of ran-
domized drug testing in health professions pro-
grams.21,38 The McWhorter School of Pharmacy at 
Samford University, Birmingham, AL, implemented 
a mandatory random urine drug-screening program 
that was integrated into its four-year curriculum.21 
This program was well received among irst-year 
pharmacy students. The Academic Anesthesiology 
Department in the Cleveland Clinic Anesthesiology 
Institute approached the process from the perspective 
of active prevention, including speciic mandatory 
education programs for all department personnel on 
a recurring basis, strengthened procedures for the 
detection and prevention of controlled substances, 
and enhanced skill-building for detection of impair-
ment.38 Additionally, that department implemented a 
multifaceted drug testing program, including random 
and “for cause” urine screens, for prevention and 
early detection of abused anesthetic drugs and other 
substances of abuse. A number of family medicine 
programs accredited by the Accreditation Council for 
Graduate Medical Education drug test their residents 
in training prior to employment.9 It appears that many 
professional schools have determined that drug test-
ing has become necessary to improve the education 
of students and the care of patients.
Professional and Ethical 
Responsibility
While the Drug-Free Schools and Communities 
Act (DFSCA) mandates that institutions of higher 
education examine methods for preventing illegal use 
of alcohol and other drugs on their campuses,11,12 in-
stitutions that provide medical and dental care should 
consider establishing a higher standard. According to 
the American Dental Association (ADA) Principles 
of Ethics and Code of Professional Conduct, “The 
dental profession holds a special position of trust 
within society. As a consequence, society afords 
the profession certain privileges that are not avail-
able to members of the public-at-large. In return, 
the profession makes a commitment to society that 
its members will adhere to high ethical standards 
of conduct.”39 As dental educators, we have an ob-
ligation to uphold, teach, and adhere to the code of 
conduct of our profession and to convey these core 
values to our students. 
Drug Testing Is Cost-Effective
Peat estimated in 1995 that the annual cost of a 
drug-testing program was less than $50,000.40 In that 
analysis, the indirect cost of dealing with the many 
issues related to illicit drug use by employees and stu-
dents far outweighed the inancial burden associated 
with direct costs associated with an MSDT program. 
According to Peat, in a longitudinal study conducted 
by the United States Postal Service (USPS) in which 
positive drug-tested employees were compared to 
negative drug-tested employees for ten years, the 
USPS had a cost savings of over $100,000,000 dur-
ing that ten-year period. These savings were a result 
of having lower rates of absenteeism, reduction in 
involuntary turnover, decrease in utilization of the 
Employee Assistance Programs, decline in the num-
ber of medical claims, and decrease in the need to 
impose disciplinary actions. Although those data are 
now 24 years old and the costs of all factors are likely 
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signiicantly diferent now, this comparison points 
to the need for careful analyses of costs of testing 
versus the costs of having employees (or students) 
who use or abuse drugs. 
According to Fitzsimons et al., when all treat-
ments and follow-up were considered, the savings for 
prevention far outweighed the cost of drug treatment, 
which was estimated to be in excess of $100,000 
per practitioner.41 They reported that the cost for 
drug treatment programs for one anesthesia resident 
can be as much as $9,000 for three to seven days of 
detoxiication and intensive medical and psychiatric 
care. In-patient treatment for 30 days costs approxi-
mately $25,000, and it is common to have residential 
treatment for up to 90 days. Outpatient treatment for 
four to eight weeks approaches $8,000. These costs 
are compounded by the fact that it takes approxi-
mately six months to return to duty after substance 
abuse events. The estimated cost of diagnosis, initial 
management, and lost clinical revenue is more than 
$60,000-$70,000 for a single resident. When the cost 
of psychiatric care, follow-up through physicians’ 
health services for three to ive years, and mandatory 
drug testing for a physician recovery are considered, 
the total cost of returning a physician to unrestricted 
medical practice is thus likely to be in excess of 
$100,000. As a result, Fitzsimons et al. concluded 
that a signiicant amount of inancial resources could 
be saved by deterring a single physician from illicit 
drug use. 
Viewpoint 2: Mandatory 
Drug Testing of Dental 
Students Carries Costs 
and Risks for Institutions 
and Students and Has 
Unproven Beneits
In the U.S., MSDT and mandatory random 
student drug testing (MRSDT) in secondary schools 
were reported in 2001 and 2002 to have become more 
widely used, with proponents advocating that it is 
a method of deterring drug use.42,43 However, both 
secondary schools and higher education institutions 
should use evidence-based practice when developing 
programs to prevent illicit use of drugs and making 
recommendations for future prevention eforts. This 
evidence-based practice should be used to address the 
most important and relevant issues for each institu-
tion and include assessment of the readiness level 
of the institution before contemplating implementa-
tion of MSDT as a preventive measure.10 Speciic 
objectives and an accurate plan must be in place by 
evaluating data on current student drug use and its 
consequences in order to improve each institution’s 
policy on prevention while maximizing its resources. 
In other words, there should be some measure of 
efectiveness. 
Four studies in secondary and higher education 
found limited empirical data to support the efective-
ness of MSDT in deterring illicit drug use.44-47 We 
found no evidence that MSDT of medical and dental 
students promotes patient safety. In the absence of 
evidence on efectiveness, educators and administra-
tors should not implement and subject all dental stu-
dents, without reasonable cause, to mandatory drug 
testing. This viewpoint argues that MSDT is not an 
efective deterrent for student drug use, can violate 
student civil liberties, inlicts a inancial burden that 
does not maximize an institution’s resources, and 
negatively afects students who receive false positive 
test results that can impact their future careers as 
health professionals; in addition, there are signiicant 
limitations of drug test panels.
Not an Effective Deterrent
In a study published in 1992 in which research-
ers evaluated college athletes who were subjected to 
MRSDT, they found little evidence that the “threat” 
of a drug test had a signiicant efect on deterring illic-
it drug use.16 Those and other researchers found little 
diference in use of illicit drugs and alcohol between 
college student athletes in the National Collegiate 
Athletic Association and Canadian Interuniversity 
Athletic Union (who were subject to random drug 
testing) and general college students.16,48,49 
Research on drug use by dental students and 
its negative consequences is minimal. In a recent 
study on dental students’ health issues presented 
as a poster at the 2017 American Dental Education 
Association (ADEA) Annual Session & Exhibition, 
71.7% of responding students self-reported using 
alcohol, and 15% reported using medications to in-
crease focus while studying.8 This study is available 
only as an abstract with limited information. Types 
of drugs used and whether students provided clini-
cal care or attended class while under the inluence 
were not reported. 
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In 2006, the U.S. Department of Education’s 
Institute of Education Sciences performed a com-
prehensive investigation of students in secondary 
schools with MRSDT and control schools that did 
not use MRSDT.46 According to its results, there was 
no diference in self-reported use of alcohol, tobacco, 
and other illicit substances between students in the 
two types of schools. Students also had similar par-
ticipation rates in extracurricular activities, there was 
no impact on the extent to which students reported 
feeling connected with their school, there were no 
spillover efects on students as they observed and 
were inluenced by the actions of their peers, and 
there was no impact on school-reported disciplinary 
incidents.46,50 In 2002, another study evaluated ef-
fectiveness of MSDT among middle and high school 
students.44,45 Those investigators found that drug-
testing policies had only a negligible diference on 
marijuana and other illicit drug use and determined 
that drug testing had failed to deter drug use. 
Potential Student Civil Liberty 
Violations
According to Bickel and Lake, court rulings 
have made it clear that colleges and universities must 
have oferings that meet minimum standards of care 
and take steps to deal with dangerous situations on 
campus; however, those institutions cannot expect to 
control student conduct.51 Institutions must also ensure 
that enforcement of sanctions is consistent among 
all identiied students, documenting that similarly 
situated ofenders are treated in a similar manner.
The U.S. Supreme Court ruled that requiring 
employees to produce urine samples constituted a 
“search” based on the Fourth Amendment of the 
U.S. Constitution, which protects citizens against 
unreasonable search and seizure.26,52 From this 
judicial interpretation, we can argue that manda-
tory drug testing of dental students must meet the 
“reasonableness” requirement of search and seizure 
under the Fourth Amendment. The “reasonableness” 
of a urine test must be based on the needs of each 
institution, such as the concern for patient safety that 
must be demonstrated by the institution and balanced 
against individual privacy rights to avoid a Fourth 
Amendment violation and potential litigation based 
on encroachment of civil liberties. 
Another constitutional issue of MSDT involves 
the Fifth Amendment, which prohibits denial of life, 
liberty, or property without “due process.”52 Denying 
students the right to continue their dental education 
based on drug test results may invoke “due process” 
considerations. Students should be given the op-
portunity to challenge the validity of test results and 
exercise the right to respond to those results prior to 
any repercussions or mandated treatment programs. 
Also, people have a fundamental right to privacy of 
their person and property under the Fifth Amendment. 
Although drug testing has been deemed legal, it may 
be challenged if testing results are divulged indiscrimi-
nately, if procedures for obtaining personal specimens 
encroach on privacy rights of the individual, or if test-
ing is imposed unnecessarily or excessively.36
Drug testing is legal; but just because some-
thing is legal does not make it ethical.26 Withholding 
a person’s right to pursue education, a career, or a 
means of livelihood based on a clinical illness such as 
SUD may not be ethical. The ethics of implementing 
such punitive actions as expulsion, loss of employ-
ment, and denial of advanced/graduate education, 
along with involvement of law enforcement based on 
a student’s chemical dependence and SUD, should 
be examined carefully. According to Swani and 
Miller, the British Medical Association and Royal 
College of Nursing do not support random drug 
testing because of major implications with regard to 
civil liberties.53 The ADA House of Delegates has 
recognized the need for research on substance abuse 
disorders among dentists, dental team members, and 
dental and dental hygiene students.54 However, the 
ADA currently does not have a policy or stance on 
mandatory drug testing for dentists and students. 
Financial Burden
According to Roach in 2005, the cost of MSDT 
programs is signiicant, ranging between $15 and 
$50 for each standard drug screening.55 From 1987 
to 1991, the average direct cost per test incurred by 
federal agencies was $74.56 The same report noted 
that, during this time period, the Department of 
Justice litigated 68 drug test-related cases, at a cost 
of $725,000. In medical education, the academic 
anesthesiology program at the Cleveland Clinic 
Anesthesiology Institute that included both pre-
employment and random drug testing estimated its 
cost to be $50,000 per year.38 
The cost of testing is not limited to the test.57 
Support personnel with appropriate training are re-
quired to discuss test results, make appropriate refer-
rals, impose disciplinary actions, monitor participa-
tion in treatment and counseling, track follow-up 
testing, and mandate intervention when necessary. 
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Meticulous documentation imposes yet another cost. 
Furthermore, in the litigious society in which we live, 
institutions will also incur the cost of legal counsel 
when they design and implement testing programs. In 
addition, there must be consistent eforts to examine 
prevention programs in order to identify gaps and 
measure outcomes and efectiveness. 
Overall, the cost of drug testing simply may 
not outweigh the beneits when test results show 
a small percentage of positive results, as found in 
Lewy’s study of drug testing of physicians in a large 
urban hospital published in 1991.58 In 2015, Bell et al. 
reported program policies and practices of incoming 
residents and medical students in family medicine 
training in the U.S.9 The majority of these programs 
(68.9%) required drug testing of incoming residents 
and had only 6.5% positive drug tests. Most of these 
programs did not require testing of medical students. 
In Lewy’s study, pre-employment urine toxicology 
examinations of 791 physicians between 1987 and 
1990 who were beginning graduate medical educa-
tion only resulted in two individuals (0.25% of the 
total) with conirmed, positive results for illegal 
drugs.58 In secondary education, Florida’s statewide 
MRSDT program to test for steroids in school athletes 
was eliminated in 2009 after only one year, partly due 
to cost.59 During the irst year of statewide implemen-
tation, New Jersey tested 150 student-athletes in 2007, 
and Illinois tested 264 student-athletes in its MSRDT 
program in 2009—both resulting in no positive tests.60,61
When the costs and resources needed to imple-
ment mandatory drug testing of all dental students are 
considered, the expense may not justify the outcomes. 
State and federal funds should not be used to subsi-
dize a drug-testing program that cannot substantiate 
its efectiveness. Limited resources of institutions 
should be spent on programs that are evidence-based. 
Drug Test Limitations and False 
Positives
Limitations in MSDT and the subsequent lack 
of efectiveness of drug tests to deter drug use are 
linked to the cycle of drug use. Drug user behavior 
is complex. Primarily, the use of the drug can be 
inluenced by the preference of the user, based on 
efects and sensation, and, secondly, by the drug “in 
fashion” and the willingness of the consumer to use 
it. As Stuart noted, drug testing using standard panels 
is limited due to the use of novel or new drugs that 
may not be included in the drug test.62 The range of 
drugs to be tested in an eight- or 14-drug panel test is 
limited, excluding other drugs of choice. Those who 
are aware of the upcoming drug test may choose to 
temporarily abstain from using illicit drugs, which 
may lead to inaccurate results and may not properly 
identify regular drug users. The half-life of the drug 
in the system and the time of testing, combined with 
advance notiication or pattern in execution of the test, 
may dictate how a student consumes or alters the dose 
prior to testing. There is substantial information on 
the Internet on how to “pass a drug test,” providing 
information to the population on how to beat a drug 
test and not get caught. Table 1 shows a drug panel 
test including alcohol that we compiled from three web-
sites that provide information on drug detection times. 
Table 1. Typical drug panel test including alcohol and drug detection time in urine, blood, saliva, and hair
Drug Detection Time
Drug In Urine In Blood In Saliva In Hair
Alcohol 3-5 days 10-12 hours 1-5 days Up to 90 days
Amphetamines 1-3 days 12 hours 1-5 days Up to 90 days
Barbiturates 2-4 days 1-2 days 1-10 days Up to 90 days
Benzodiazepines 3-6 weeks 2-3 days 1-10 days Up to 90 days
Cannabis 7-30 days Up to 2 weeks 1-10 days Up to 90 days
Cocaine 3-4 days 1-2 days 1-10 days Up to 90 days
Heroin 3-4 days 12 hours 1-4 days Up to 90 days
LSD 1-3 days 2-3 hours 1-2 days Up to 90 days
MDMA (Ecstasy) 3-4 days 1-2 days 1-5 days Up to 90 days
Methamphetamines (crystal meth) 3-6 days 24-72 hours 1-4 days Up to 90 days
Methadone 3-4 days 24-36 hours 1-10 days Up to 90 days
Morphine 2-3 days 6-8 hours 1-4 days Up to 90 days
Propoxyphene (opiate) 1-2 days Up to 2 days 1-2 days Up to 90 days
Source: Data compiled from www.drugs.ie/drugs_info/about_drugs/how_long_do_drugs_stay_in_your_system/, www.passyourdrugtest.
com/timetable.htm, and alwaystestclean.com/drug-detection-times-chart/. 
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The issue of false-positive test results is one 
that has caught the attention of researchers and media, 
as reported by DuPont et al.63 Although the purpose 
of implementing MSDT is to deter illicit drug use, 
the reality is that it can adversely afect the profes-
sional development of those identiied. Illegal use of 
drugs is subject to the institution’s sanctions as well 
as to criminal sanctions provided by federal, state, 
and local laws.1 The identiied students in one dental 
school may face punitive programs with academic 
consequences that range from expulsion to mandated 
enrollment in a program that involves law enforce-
ment.15 In addition, institutions with mandatory 
drug testing may have policies that require students 
who have tested positive to be responsible for any 
cost related to retests even though the possibility of 
false positive tests may exist, as at the University of 
Missouri.13 There have also been cases of students 
who tested positive for banned substances that were 
used legally for medical reasons.36 Furthermore, if 
the possession of an illicit drug is reported to law 
enforcement, the record of drug use may follow 
that student even after leaving school. A national 
survey of drug prevention coordinators in secondary 
schools reported in 2009 the presence of punitive 
practices that contradicted the federal guidelines 
regarding non-punitive consequences on students 
who tested positive.64 Reports of incidents in which 
law enforcement is involved are available through 
a criminal background check (CBC). In the U.S., 
Rutgers School of Dental Medicine conditionally 
admits students based on results of a CBC.65
In health-related professions that require per-
mits or licensure, we have found that questions in 
the application process require disclosure of the use 
of any illicit drug or controlled substances. We have 
observed that the same applies, in some instances, 
in centralized health professions school applications, 
in which the applicant must disclose any past history 
in violation of student conduct or illegal activity. 
Other consequences associated with the impact of 
false positives in an academic setting may be related 
to interpersonal relationship stressors with peers, 
teachers, and academic administrators involved in 
the case, as found in Levy and Schizer’s study of 
adolescent drug testing in schools.66 MSDT can lead 
to a negative educational environment among stu-
dents, faculty, and staf that can include trust issues, 
stress, stigma, and biases that may be detrimental to 
the professional development of students.
Response by Drs. Gibson, Loza-Herrero, and 
Yepes to Viewpoint 2:
We agree with Viewpoint 2 that higher educa-
tion institutions cannot expect to control student 
conduct; after all, students are adults whose rights and 
privileges are protected under the U.S. Constitution. 
However, institutions that train future professionals 
who provide medical and dental care to patients must 
consider establishing a higher standard. As dental 
educators, we have an obligation to uphold, teach, 
and adhere to the code of conduct of our profession 
and to convey these core values to our students. Cer-
tainly, many professional schools have determined 
that drug testing has become necessary to improve 
the education of students and the care of patients. The 
ADA House of Delegates recognized the need for re-
search on substance abuse disorders among dentists, 
dental team members, and dental and dental hygiene 
students because, as leaders in the dental community, 
the delegates understand that health care providers 
working under the inluence of drugs are a threat to 
public safety. Many schools of medicine, pharmacy, 
nursing, dentistry, and residency programs perform 
mandatory drug testing and implement multifaceted 
drug testing programs, including random and “for 
cause” urine screens, for prevention and early detec-
tion of SUD, for the well-being of patients, and to 
increase the public’s trust. 
As the authors of Viewpoint 2 conirmed, in 
the U.S., as long as there is adherence to the Fourth 
and the Fifth Amendments, the Supreme Court has 
ruled in favor of MSDT, alleviating any concerns 
regarding violation of student civil liberties. Where 
we vehemently disagree with Viewpoint 2 is that 
the inancial burden associated with MSDT is too 
signiicant to implement. We reiterate our position 
that the indirect cost of dealing with the many issues 
related to illicit drug use in students far outweighs the 
inancial burden associated with direct costs associ-
ated with implementing an MSDT program.
Response by Drs. Kim-Berman, Dilbone, and 
Perez to Viewpoint 1:
Although we agree with the authors of View-
point 1 that instilling professional and ethical conduct 
in students to ensure public safety and assisting stu-
dents at risk for substance use disorder should be a 
focus of dental educators, a decision by educational 
institutions to engage in mandatory drug testing of 
students is not based on any currently available evi-
dence. Given the review of the many issues of MSDT 
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and the viewpoints expressed, we continue to assert 
that there is no advantage of implementing MSDT 
in dental schools for all students in the absence of 
empirical data supporting its efectiveness. Although 
MSDT is legal and there are hospitals and medical 
and dental schools that are currently drug-testing 
students and residents, evidence of universal MSDT 
that has resulted in increased patient safety, improved 
student well-being, and prevention and deterrence 
of substance use is not yet available. Prevention 
systems must be designed based on a thorough needs 
assessment of the objective data, establishment of 
metrics to measure objectives, and implementation 
of prevention activities that research has shown to 
be efective. The results of the prevention program 
should be continually reined to improve the pro-
gram’s objectives. Additionally, success of a drug-
testing program depends on widespread cooperation 
and engagement in the implementation and regular 
review from all the stakeholders including students, 
faculty, leadership, and community.
A possible alternative to suspicion-less drug 
testing of all students may be implementation of 
suspicion-based testing, which some universities and 
dental schools have adopted. Drug testing of students 
under suspicion programs is based on reasonable 
cause, which may consist of observation of drug 
possession or use, a pattern of erratic behavior or 
physical symptoms, or arrest/conviction for a drug-
related ofense. “For cause” testing may also promote 
responsible use of valuable and limited resources 
by the educational institutions without negatively 
impacting their students since the focus is on those at 
risk for drug abuse. This kind of testing may also help 
avoid potential litigation and ensure public safety.
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